Hypoglycemia and diabetes: A report of aworkgroup of the American diabetes association and the endocrine society

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1384-1395

  Seaquist, Elizabeth R ^a   Anderson, John ^b   Childs, Belinda ^c   Cryer, Philip ^d   Dagogo Jack, Samuel ^e   Fish, Lisa ^f   Heller, Simon R ^g   Rodriguez, Henry ^h   Rosenzweig, James ⁱ   Vigersky, Robert ^j  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Frist Clinic   (United States)

^c Mid America Diabetes Associates PA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f PARK NICOLLET CLINIC   (United States)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WALTER REED ARMY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCAGON; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; SULFONYLUREA DERIVATIVE;

AGE DISTRIBUTION; AWARENESS; BLOOD GLUCOSE MONITORING; BREAST FEEDING; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; EXERCISE; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LENGTH OF STAY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PATIENT EDUCATION; PREGNANCY; PUBERTY; QUALITY OF LIFE; REVIEW; RISK REDUCTION; STRATEGIC PLANNING;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84876796916     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2480     Document Type: Review

References (125)

1. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-1249
2. Cryer PE, Axelrod L, Grossman AB, et al.; Endocrine Society. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709-728
3. Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
4. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)
5. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
6. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301:1565-1572
7. Perantie DC, Lim A, Wu J, et al. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9: 87-95 (Pubitemid 351560357)
8. Perantie DC, Koller JM, Weaver PM, et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes 2011;60:3006-3014
9. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988;37:901-907 (Pubitemid 19043718)
10. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes melli-tus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.J Clin Invest 1993;91:819-828 (Pubitemid 23095255)
11. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counter-regulation in normal humans. Diabetes 1997;46:1328-1335 (Pubitemid 27315282)
12. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991;40:223-226
13. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglyce-mic symptoms in patients with poorly controlled diabetes and in nondiabe-tics. N Engl J Med 1988;318:1487-1492
14. Cryer PE. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 2009;52:35-37
15. Cryer P. The prevention and correction of hypoglycemia. In Handbook of Physiology: Section 7, The Endocrine System, Volume II, The Endocrine Pancreas and Regulation of Metabolism. Jefferson LS, Cherring AD, Eds. New York, Oxford University Press, 2001, p. 1057-1092
16. Freckmann G, Baumstark A, Jendrike N, et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010;12:221-231
17. Klonoff DC, Buckingham B, Christiansen JS, et al.; Endocrine Society. Continuous glucose monitoring: An Endocrine Society Clinical Practice Guideline. J Clin Endo-crinol Metab 2011;96:2968-2979
18. Karon BS, Boyd JC, Klee GG. Glucose meter performance criteria for tight gly-cemic control estimated by simulation modeling. Clin Chem 2010;56:1091-1097
19. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10: 622-628 (Pubitemid 17158937)
20. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143-1148 (Pubitemid 30616803)
21. DexCom Seven Plus Continuous Glucose Monitoring System User's Guide [article online], 2012. Available from http://dexcom.com/sites/dexcom.com/files/ seven-plus/docs/SEVEN-Plus-Users- Guide.pdf and http://dexcom.com/sites/dexcom. com/files/LBL-011119-Rev-07- User's-Guide,-G4-US.pdf. Accessed 9 April 2012
22. Medtronic Guardian Real-Time Continuous Glucose Monitoring System User Guide [article online], 2012. Available from http://www.medtronicdiabetes. com/support/download-library/userguides. Accessed 29 April 2012
23. Heller SR, Choudhary P, Davies C, et al.; UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50:1140-1147 (Pubitemid 46701541)
24. Donnelly LA, Morris AD, Frier BM, et al.; DARTS/MEMO Collaboration. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabet Med 2005;22:749-755 (Pubitemid 40805897)
25. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
26. Cryer PE. Death during intensive glyce-mic therapy of diabetes: mechanisms and implications. Am J Med 2011;124: 993-996
27. Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007;50:2439-2442 (Pubitemid 350060644)
28. Jacobson AM, Musen G, Ryan CM, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-1852 (Pubitemid 46698465)
29. Feltbower RG, Bodansky HJ, Patterson CC, et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of Diabetes in Children and Young Adults. Diabetes Care 2008;31: 922-926
30. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Longterm mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298-305 (Pubitemid 43185398)
31. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010; 16:244-248
32. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration ofhypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344:283-287 (Pubitemid 24230294)
33. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterreg-ulation, in IDDM. Diabetes 1994;43: 1426-1434
34. Fanelli C, Pampanelli S, Epifano L, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypo-glycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994;37:1265-1276 (Pubitemid 24356767)
35. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983;308:485-491 (Pubitemid 13195475)
36. Bo lli GB, De Feo P, De Cosmo S, et al. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 1984; 33:732-737 (Pubitemid 14053513)
37. Zammitt NN, Warren RE, Deary IJ, Frier BM. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemia. Diabetes 2008;57:732-736
38. Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE. Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: A mechanism for hypoglyce-mia-associated autonomic failure. Diabetes 2008;57:470-475
39. Jaferi A, Nowak N, Bhatnagar S. Negative feedback functions in chronically stressed rats: role of the posterior paraventricular thalamus. Physiol Behav 2003;78:365-373 (Pubitemid 36372078)
40. Puente EC, Silverstein J, Bree AJ, et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypogly-cemia. Diabetes 2010;59:1055-1062
41. Reno CM, Tanoli T, Puente EC, et al. Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract). Diabetes 2011;60(Suppl. 1): A81
42. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl. 12):134-145
43. Silverstein J, Klingensmith G, Copeland K, et al.; American Diabetes Association. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care 2005;28:186-212 (Pubitemid 40095803)
44. Hannonen R, Tupola S, Ahonen T, Riikonen R. Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypo-glycaemia. Dev Med Child Neurol 2003; 45:262-268 (Pubitemid 36372208)
45. Bolo NR, Musen G, Jacobson AM, et al. Brain activation duringworkingmemory is altered in patients with type 1 diabetes during hypoglycemia. Diabetes 2011;60: 3256-3264
46. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemio-logical analysis of the ACCORD study. BMJ 2010;340:b4909
47. Zoungas S, Patel A, Chalmers J, et al.; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363:1410-1418
48. Punthakee Z, Miller ME, Launer LJ, et al.; ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hy-poglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35: 787-793
49. Launer LJ, Miller ME, Williamson JD, et al.; ACCORD MIND Investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol 2011;10:969-977
50. Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002;25:471-475 (Pubitemid 41103338)
51. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997;157:1681-1686 (Pubitemid 27327403)
52. Heinsimer JA, Lefkowitz RJ. The impact of aging on adrenergic receptor function: clinical and biochemical aspects. J Am Geriatr Soc 1985;33:184-188 (Pubitemid 15137412)
53. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994;43:403-410 (Pubitemid 24064247)
54. Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L; European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37(Suppl. 3):S27-S38
55. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002;51:724-733 (Pubitemid 34760182)
56. Burge MR, Sobhy TA, Qualls CR, Schade DS. Effect of short-term glucose control on glycemic thresholds for epi-nephrine and hypoglycemic symptoms. J Clin Endocrinol Metab 2001;86: 5471-5478 (Pubitemid 33070277)
57. Bruce DG, Casey GP, Grange V, et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes Res Clin Pract 2003;61:59-67 (Pubitemid 36808844)
58. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes Care 2008;31:233-235 (Pubitemid 351222517)
59. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997;20:438-445 (Pubitemid 27098239)
60. Pandya N, Thompson S, Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. J Am Med Dir Assoc 2008;9:663-669
61. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60:616-631
62. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
63. Aubert RE, Geiss L, Ballard DJ, Cocanougher B, Herman W. Diabetes-Related Hospitalization and Hospital Utilization. Bethesda, MD, National Institutes of Health, 1995
64. Clement S, Braithwaite SS, Magee MF, et al.; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hy-perglycemia in hospitals. Diabetes Care 2004;27:553-591
65. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyper-glycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982 (Pubitemid 36121050)
66. Bucerius J, Gummert JF, Walther T, et al. Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg 2003;51:11-16 (Pubitemid 36603939)
67. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001;32:2426-2432 (Pubitemid 32954818)
68. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001;17:107-124 (Pubitemid 32163181)
69. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
70. Brunkhorst FM, Engel C, Bloos F, et al.; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
71. Finfer S, Chittock DR, Su SY, et al.; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297
72. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-827
73. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354: 449-461 (Pubitemid 43200296)
74. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008;300:933-944
75. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbid-ities. Am J Med 2011;124:1028-1035
76. Krinsley JS, Grover A. Severe hypogly-cemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35: 2262-2267 (Pubitemid 47476221)
77. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009;32:1153-1157
78. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002 (Pubitemid 351656454)
79. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight non-diabetic pregnant women. Am J Obstet Gynecol 2004;191:949-953 (Pubitemid 39298139)
80. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med 2012;29:558-566
81. Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normaland abnormalglucose metabolismin pregnancy. J Matern Fetal Neonatal Med 2012;25:1171-1175
82. Riviello C, Mello G, Jovanovic LG. Breastfeeding and the basal insulin requirement in type 1 diabetic women. Endocr Pract 2009;15:187-193
83. Barendse S, Singh H, Frier BM, Speight J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: A narrative review. Diabet Med 2012;29:293-302
84. King P, Kong MF, Parkin H, Macdonald IA, Tattersall RB. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998;21:341-345 (Pubitemid 28101066)
85. Gold AE, Deary IJ, Frier BM. Hypo-glycaemia and non-cognitive aspects of psychological function in insulin-dependent (type 1) diabetes mellitus (IDDM). Diabet Med 1997;14:111-118 (Pubitemid 27095025)
86. Strachan MW, Deary IJ, Ewing FM, Frier BM. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 2000;23:305-312 (Pubitemid 30131735)
87. Ritholz MD, Jacobson AM. Living with hypoglycemia. J Gen Intern Med 1998; 13:799-804 (Pubitemid 29009291)
88. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21:1477-1483 (Pubitemid 41368581)
89. Cox DJ, Gonder-Frederick L, Clarke W. Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes 1993;42:239-243 (Pubitemid 23045026)
90. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance: occurrence, awareness and correction. Diabetes Care 2000; 23:163-170 (Pubitemid 30071018)
91. Quillian WC, Cox DJ, Gonder-Frederick LA, Driesen NR, Clarke WL. Reliability of driving performance during moderate hypoglycemia in adults with IDDM. Diabetes Care 1994;17:1367-1368 (Pubitemid 24324991)
92. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991;90:450-459
93. Cox DJ, Kovatchev B, Vandecar K, Gonder-Frederick L, Ritterband L, Clarke W. Hypoglycemia preceding fatal car collisions. Diabetes Care 2006;29:467-468 (Pubitemid 44106547)
94. Eadington DW, Frier BM. Type 1 diabetes and driving experience: An eight-year cohort study. Diabet Med 1989;6:137-141 (Pubitemid 19058813)
95. Lave LB, Songer TJ, LaPorte RE. Should persons with diabetes be licensed to drive trucks?dRisk management. Risk Anal 1993;13:327-334 (Pubitemid 23188957)
96. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379
97. Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;2:CD003417
98. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: A systematic review of randomized controlled trials. Diabetes Care 2001;24:561-587 (Pubitemid 32198430)
99. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: A meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159-1171 (Pubitemid 41071167)
100. Mu€hlhauser I, Berger M. Patient educationd evaluation of a complex intervention. Di-abetologia 2002;45:1723-1733 (Pubitemid 35478144)
101. Bott S, Bott U, Berger M, Mu€hlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997;40:926-932 (Pubitemid 27316573)
102. Sämann A, M€uhlhauser I, Bender R, Kloos Ch, M€uller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: A prospective implementation study. Dia-betologia 2005;48:1965-1970 (Pubitemid 41416904)
103. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325: 746
104. McIntyre HD, Knight BA, Harvey DM, Noud MN, Hagger VL, Gilshenan KS. Dose adjustment for normal eating (DAFNE)dan audit of outcomes in Australia. Med J Aust 2010;192:637-640
105. Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care 2012;35:1638-1642
106. Cox DJ, Gonder-Frederick L, Ritterband L, Clarke W, Kovatchev BP. Prediction of severe hypoglycemia. Diabetes Care 2007;30:1370-1373 (Pubitemid 46871140)
107. Fritsche A, Stefan N, Häring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001; 134:729-736 (Pubitemid 32402065)
108. Gray RO, Butler PC, Beers TR, Kryshak EJ, Rizza RA. Comparison of the ability of bread versus bread plus meat to treat and prevent subsequent hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:1508-1511 (Pubitemid 26118584)
109. Kalergis M, Schiffrin A, Gougeon R, Jones PJ, Yale JF. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: A randomized, placebo-controlled, crossover trial. Diabetes Care 2003;26:9-15 (Pubitemid 36928988)
110. Kaufman FR, Halvorson M, Kaufman ND. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995;30:205-209 (Pubitemid 26147053)
111. Raju B, Arbelaez AM, Breckenridge SM, Cryer PE. Nocturnal hypoglycemia in type 1 diabetes: An assessment of preventive bedtime treatments. J Clin En-docrinol Metab 2006;91:2087-2092 (Pubitemid 43854987)
112. Ververs MT, Rouwé C, Smit GP. Complex carbohydrates in the prevention of nocturnal hypoglycaemia in diabetic children. Eur J Clin Nutr 1993;47:268-273 (Pubitemid 23111666)
113. Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin 2001;19:489-505 (Pubitemid 32852083)
114. Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH; American Diabetes Association. Physical activity/exercise and diabetes mellitus. Diabetes Care 2003;26(Suppl. 1):S73-S77 (Pubitemid 36928961)
115. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002; 19:746-751 (Pubitemid 35013853)
116. Leitão CB, Tharavanij T, Cure P, et al. Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008;31:2113-2115
117. Meyer C, Hering BJ, Grossmann R, et al. Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mel-litus. Transplantation 1998;66:233-240 (Pubitemid 28370007)
118. Paty BW, Lanz K, Kendall DM, Sutherland DE, Robertson RP. Restored hypogly-cemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 2001;72:1103-1107 (Pubitemid 32924085)
119. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987;316:1376-1383 (Pubitemid 17079681)
120. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypo-glycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypo-glycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42:1683-1689 (Pubitemid 23318128)
121. Dagogo-Jack S, Fanelli CG, Cryer PE. Durable reversal of hypoglycemia un-awareness in type 1 diabetes. Diabetes Care 1999;22:866-867 (Pubitemid 29220806)
122. Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 2011;34:50-52
123. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hy-poglycemia: reduction in nocturnal hy-poglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025
124. Smith CB, Choudhary P, Pernet A, Hopkins D, Amiel SA. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit. Diabetes Care 2009; 32:1196-1198
125. Dagogo-Jack S. Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention. Treat Endocrinol 2004;3: 91-103 (Pubitemid 38337560)